The Independent·3 min read·medium
Weight loss drugs linked to loss of hair in major new study
J
Jane Kirby
✦AI Summary
A new study involving 50,000 participants suggests a link between GLP-1 agonist weight loss drugs like Wegovy, Ozempic, and Mounjaro and an increased risk of hair loss. Regulatory bodies in the US and UK have received hundreds of reports from patients experiencing alopecia while using these medications.
The study looked at 50,000 people on GLP-1 agonist drugs such as Wegovy and Mounjaro
healthscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in